BECK MACK & OLIVER LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 35 filers reported holding CANCER GENETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BECK MACK & OLIVER LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q2 2016$36,000
-35.7%
18,225
-7.1%
0.00%
-50.0%
Q1 2016$56,000
-13.8%
19,6250.0%0.00%0.0%
Q4 2015$65,000
-60.1%
19,625
+8.6%
0.00%
-50.0%
Q3 2014$163,000
-21.6%
18,075
-1.6%
0.00%
-20.0%
Q2 2014$208,000
-24.9%
18,3750.0%0.01%
-16.7%
Q1 2014$277,000
+11.2%
18,375
+1.5%
0.01%0.0%
Q4 2013$249,000
-6.0%
18,100
+38.2%
0.01%
-14.3%
Q3 2013$265,000
+103.8%
13,1000.0%0.01%
+75.0%
Q2 2013$130,00013,1000.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders